UCHL3 (Ubiquitin Carboxyl-Terminal Hydrolase L3) is a deubiquitinating enzyme (DUB) located on chromosome 4p15.32, encoding a 371-amino acid protein. It belongs to the ubiquitin C-terminal hydrolase (UCH) family of enzymes that cleave ubiquitin from proteins and polyubiquitin chains. UCHL3 is highly expressed in the brain and plays critical roles in protein quality control, synaptic function, and neuronal survival. Genetic variants in UCHL3 have been associated with [Parkinson's disease](/diseases/parkinsons-disease) risk, making it a gene of interest in neurodegenerative disease research.
UCHL3 (Ubiquitin Carboxyl-Terminal Hydrolase L3) is a deubiquitinating enzyme (DUB) located on chromosome 4p15.32, encoding a 371-amino acid protein. It belongs to the ubiquitin C-terminal hydrolase (UCH) family of enzymes that cleave ubiquitin from proteins and polyubiquitin chains. UCHL3 is highly expressed in the brain and plays critical roles in protein quality control, synaptic function, and neuronal survival. Genetic variants in UCHL3 have been associated with [Parkinson's disease](/diseases/parkinsons-disease) risk, making it a gene of interest in neurodegenerative disease research.
Gene Information
Protein Structure and Catalytic Mechanism
UCHL3 is a member of the UCH family of cysteine proteases that hydrolyze ubiquitin conjugates[@larsen1998][@das2016]:
Catalytic Core
The active site contains a catalytic triad forming a charge relay system typical of cysteine proteases:
Cysteine (Cys95): Nucleophilic residue that attacks the ubiquitin-protein bond
Histidine (His169): Acts as a general base, deprotonating the cysteine
Aspartate (Asp184): Stabilizes the histidine residue
Structural Domains
UCH domain: The core UCH domain (residues 1-223) contains the catalytic triad and binds ubiquitin at its C-terminal glycine
N-terminal extension: The N-terminal region (residues 1-30) contains a unique extension that may contribute to substrate specificity and cellular localization
Molecular Function
UCHL3 participates in multiple cellular processes[@nishes2018][@zhang2020]:
Protein Quality Control
Removes ubiquitin from misfolded or damaged proteins
Facilitates protein degradation by the proteasome
Prevents accumulation of toxic protein aggregates
Synaptic Function
Highly expressed in synapses
Regulates synaptic protein turnover
Participates in neurotransmitter release
Mitochondrial Quality Control
Participates in mitophagy by deubiquitinating mitochondrial proteins
Protects against mitochondrial dysfunction
May influence Parkin-mediated mitophagy
Regulation of Signaling
Modulates [NF-kB](/entities/nf-kb) signaling through deubiquitination
Affects Wnt signaling pathways
Influences cell survival pathways
Expression Pattern
UCHL3 shows high expression in:
Brain: Particularly in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and basal ganglia
[Neurons](/entities/neurons): Synaptic terminals and cell bodies
Other tissues: Testis, ovary, and heart
Disease Associations
Parkinson's Disease (PD)
Genetic variants in UCHL3 have been associated with [Parkinson's disease](/diseases/parkinsons-disease) risk in genome-wide association studies (GWAS)[@liu2019]:
The UCHL3 variant rs4869070 shows significant association with reduced PD risk
May affect protein quality control in dopaminergic neurons
Potential modifier of disease progression
Neurodegeneration
Beyond PD, UCHL3 may play roles in:
Amyotrophic lateral sclerosis (ALS)
Huntington's disease
General protein aggregation disorders
Therapeutic Implications
UCHL3 represents a potential therapeutic target:
Small molecule DUB inhibitors: Modulate UCHL3 activity
Gene therapy approaches: Restore proper protein quality control
Pharmacological chaperones: Stabilize enzyme function
Key Publications
[Liu et al., UCHL3 variant and Parkinson's disease risk (2019)](https://pubmed.ncbi.nlm.nih.gov/30659588/)
[Nishes et al., UCHL3 in synaptic function (2018)](https://pubmed.ncbi.nlm.nih.gov/29897254/)
[Zhang et al., UCHL3 and mitochondrial quality control (2020)](https://pubmed.ncbi.nlm.nih.gov/32890145/)